Adding corticosteroids to standard intravenous (IV) immunoglobulin treatment for children with Kawasaki disease judged to be at higher risk of developing blood vessel complications made initial treatment more successful and prevented these complications. According to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart